Emicizumab reduces re-hospitalization for bleeding in acquired haemophilia A.

Chen, Sheh-Li; Ellsworth, Patrick; Kasthuri, Raj S; Moll, Stephan; Ma, Alice D; Key, Nigel S

Chen, Sheh-Li; Ellsworth, Patrick; Kasthuri, Raj S; Moll, Stephan; Ma, Alice D; Key, Nigel S.

Afiliación

Chen SL; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA.
Ellsworth P; Department of Medicine, Division of Hematology and Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Kasthuri RS; Department of Medicine, Division of Hematology and Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Moll S; Department of Medicine, Division of Hematology and Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Ma AD; Department of Medicine, Division of Hematology and Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Key NS; Department of Medicine, Division of Hematology and Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Haemophilia ; 27(4): e585-e588, 2021 Jul.

Article en En | MEDLINE | ID: mdl-34050698

Asunto(s)

Anticuerpos Biespecíficos; Hemofilia A; Anticuerpos Monoclonales Humanizados/uso terapéutico; Hemofilia A/complicaciones; Hemofilia A/tratamiento farmacológico; Hospitalización; Humanos

Palabras clave

acquired hemophilia A; emicizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Hemofilia A Límite: Humans Idioma: En Revista: Haemophilia Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google